Indicators

Markets:

News

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9

...

Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs

September 24, 2023

Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression

September 21, 2023

Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here

September 21, 2023

Healthcare Providers Can Offer Ketamine Treatment On Employee Insurance Plans

September 20, 2023

Congress To Discuss New Bill Banning Federal Intervention In States Where Psilocybin Is Legal

September 20, 2023

Kentucky's $42M Ibogaine Budget Plan For Opioid Crisis Hears Testimonies At Second Meeting

September 19, 2023

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More

September 18, 2023

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic

September 18, 2023

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update

September 18, 2023

Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News

September 15, 2023

Combining MDMA With Psilocybin Or LSD Could Reduce Difficult Trips, New Study Shows

September 13, 2023

Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative

September 13, 2023

Congress Update: House Committee Green Lights Psychedelics Amendments

September 13, 2023

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years

September 12, 2023

Michigan Resolution: Veterans Across US Should Have Access To Psychedelic-Assisted Therapy

September 08, 2023

'Wolf Of Wall Street' Embraces Ibogaine For Addiction Recovery With Help Of 'Psychedelic Concierge'

September 08, 2023

Optimi Health Will Supply Psychedelics To Canada's SAP, Secures CA$1M Private Financing

September 08, 2023

Shaping Federal Policy Around Psychedelic Therapy: APPA Teams Up With Daschle Group

September 07, 2023

Psychedelics Reform Update: CA Bill's Final Vote, MA 2024 Legalization Ballot, HI Task Force, OR Funding And More

September 07, 2023

Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program

September 06, 2023

PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application

September 06, 2023

Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression

September 06, 2023

Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT

September 05, 2023

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More

September 05, 2023

Sacred Medicine Meets Wall Street: Legal Peyote Company Will Trade On Canadian Market

September 04, 2023

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, New Usona Phase 2 Trial Shows

September 03, 2023

Pete Davidson Reveals He's Tried Ketamine To Cope With Depression

September 01, 2023

UK Psychedelics Update: MPs Seek Rescheduling, Safe Consumption Sites, OD Prevention Fund

September 01, 2023

Colorado's Psychedelic Future Unfolds: Regulators Host Community Meetings To Shape Industry Rules

August 31, 2023

Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions

August 31, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.